Molecular Biology of the Cell click for CBE Life Science Education Page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E05-01-0055 on June 1, 2005

Vol. 16, Issue 8, 3632-3641, August 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E05-01-0055v1
16/8/3632    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scicchitano, B. M.
Right arrow Articles by Adamo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scicchitano, B. M.
Right arrow Articles by Adamo, S.

Vasopressin-dependent Myogenic Cell Differentiation Is Mediated by Both Ca2+/Calmodulin-dependent Kinase and Calcineurin Pathways

Bianca Maria Scicchitano *, Lucia Spath *, Antonio Musarò * {dagger}, Mario Molinaro *, Nadia Rosenthal {ddagger}, Clara Nervi *, and Sergio Adamo * {dagger}

* Department of Histology and Medical Embryology, University of Rome "La Sapienza," 00161 Roma, Italy; {dagger} Interuniversity Institute of Myology, University of Rome "La Sapienza," 00161 Roma, Italy; and {ddagger} Mouse Biology Programme, European Molecular Biology Laboratory, 00016 Monterotondo, Italy

Submitted January 21, 2005; Revised May 11, 2005; Accepted May 24, 2005
Monitoring Editor: Marianne Bronner-Fraser

Arg8-vasopressin (AVP) promotes the differentiation of myogenic cell lines and mouse primary satellite cells by mechanisms involving the transcriptional activation of myogenic bHLH regulatory factors and myocyte enhancer factor 2 (MEF2). We here report that AVP treatment of L6 cells results in the activation of calcineurin-dependent differentiation, increased expression of MEF2 and GATA2, and nuclear translocation of the calcineurin target NFATc1. Interaction of these three factors occurs at MEF2 sites of muscle specific genes. The different kinetics of AVP-dependent expression of early (myogenin) and late (MCK) muscle-specific genes correlate with different acetylation levels of histones at their MEF2 sites. The cooperative role of calcineurin and Ca2+/calmodulin-dependent kinase (CaMK) in AVP-dependent differentiation is demonstrated by the effect of inhibitors of the two pathways. We show here, for the first time, that AVP, a "novel" myogenesis promoting factor, activates both the calcineurin and the CaMK pathways, whose combined activation leads to the formation of multifactor complexes and is required for the full expression of the differentiated phenotype. Although MEF2–NFATc1 complexes appear to regulate the expression of an early muscle-specific gene product (myogenin), the activation of late muscle-specific gene expression (MCK) involves the formation of complexes including GATA2.


This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E05–01–0055) on June 1, 2005.

Abbreviations used: AVP, arg8-vasopressin; CaMK, calcium/calmodulin-dependent kinase; CSA, cyclosporin A; HDAC, histone deacetylase; MCK, muscle creatine kinase; MEF2, myocyte enhancer factor 2; MHC, myosin heavy chain; NFAT, nuclear factor of activated T-cells.

Address correspondence to: Sergio Adamo (sergio.adamo{at}uniroma1.it).




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. A. H. Smith, T. A. Kohn, A. K. Chetty, and E. O. Ojuka
CaMK activation during exercise is required for histone hyperacetylation and MEF2A binding at the MEF2 site on the Glut4 gene
Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E698 - E704.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. Stupka, J. D. Schertzer, R. Bassel-Duby, E. N. Olson, and G. S. Lynch
Stimulation of calcineurin A{alpha} activity attenuates muscle pathophysiology in mdx dystrophic mice
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R983 - R992.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Gutkowska, M. Miszkurka, B. Danalache, N. Gassanov, D. Wang, and M. Jankowski
Functional arginine vasopressin system in early heart maturation
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2262 - H2270.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Gassanov, M. Jankowski, B. Danalache, D. Wang, R. Grygorczyk, U. C. Hoppe, and J. Gutkowska
Arginine Vasopressin-mediated Cardiac Differentiation: INSIGHTS INTO THE ROLE OF ITS RECEPTORS AND NITRIC OXIDE SIGNALING
J. Biol. Chem., April 13, 2007; 282(15): 11255 - 11265.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2005 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.